MedX Health Corp. is a North American healthcare company that operates in the medical devices and instruments industry. MedX Health is specialized in the development, production and commercialization of phototherapy devices and software for various medical purposes, including pain relief, wound healing and esthetic and dental applications.
MedX Health Corp is a public healthcare corporation with listing on the Toronto Venture Stock Exchange. The company’s ordinary shares are traded under the stock quote MDX.
The Mississauga-based medical instruments manufacturer is primarily focused on skin health detection and treatment solutions. The company provides teledermatological solutions through its cloud-based telemedicine platform called DermSecure. It is also a secured patient management system that integrates and syncs the electronic medical records of patients.
The company’s proprietary technology enables the SIAscope device to capture five images, which includes four spectrophotometric images two millimeters below the skin. These images indicate any type of disorganization in the skin, such as a mole or lesion. Thus, SIAscope technology provides an additional critical imaging solution that helps skin doctors/ dermatologists to assess the underlying physiological structure and disorders in the skin. It provides a full assessment and diagnosis of tiny mole and skin disruptions, such as dermatoscopic, hemoglobin, pigmentation, dermal pigmentation, and collagen.
The company works with low barrier-to-entry partners, including medical clinics, spas, pharmacies, and physician offices to provide access to rapid mole scanning to patients. The healthcare providers and patients are provided a detailed assessment of results within two business days with remedial steps and recommendations.
When it comes to information security, MedX deploys the latest security measures, conducts third party threat testing and ensures real time monitoring. The company works in compliance to global privacy regulations, including GDPR, HIPAA and PIPEDA.
MedX Health markets and distributes its phototherapeutic medical devices worldwide, and earns a significant portion of its revenue from the United States and Canada.